- Your cart is empty
- Continue Shopping
How Many People Have HIV/AIDS Globally and in Nigeria? [2025 Statistics]
- Stats & Data
- Posted on
-
by enavec_pharmacy
- 0 comments
![How Many People Have HIV/AIDS Globally and in Nigeria? [2025 Statistics]](https://enavecpharmacy.com/wp-content/uploads/2026/04/Designer-11.png)
📊 Statistics & Data Report
Global
Africa
Nigeria
UNAIDS 2025
Updated 2025
How Many People Have HIV/AIDS Globally and in Nigeria? [2025 Statistics]
40.8 million people live with HIV worldwide. Nigeria has the 4th highest number of cases on earth. Every number below is sourced from UNAIDS, WHO, NACA, and peer-reviewed studies — verified and dated.
🔬 Primary Answer
40.8M
People living with HIV globally at the end of 2024
Source: UNAIDS 2025 Global AIDS Update · UNAIDS/WHO Estimates, 2025
🔍 Commonly Searched Topics
- How many people have HIV in Nigeria 2025?
- HIV death rate Africa / worldwide
- What percentage of Nigerians have HIV?
- Difference between HIV and AIDS
- Can HIV be cured in 2025?
- HIV transmission routes Nigeria
🌍 Where Readers Come From
- Nigeria — 4th highest HIV burden globally
- South Africa, Kenya, Mozambique, Uganda
- Eastern & Southern Africa — 21.1M cases
- United States — 1.2M people living with HIV
- United Kingdom & Europe
- Healthcare professionals & researchers
🌐
Section 1
Global Prevalence — The Big Numbers
The UNAIDS 2025 Global AIDS Update, published July 2025, provides the most comprehensive picture of the HIV epidemic ever assembled. These are the headline statistics for 2024.
40.8M
People living with HIV globally (2024)
39.4 million adults (15+) and 1.4 million children (0–14). 53% of all people living with HIV are women and girls.
UNAIDS / WHO Estimates, 2025
1.3M
New HIV infections in 2024
A 61% decline from the peak of 3.4 million in 1996 — but still 3.5× the 2025 global target of fewer than 370,000 new infections.
UNAIDS 2025 Global AIDS Update
630,000
AIDS-related deaths in 2024
One person died of HIV-related causes every single minute in 2024. A 70% reduction from the 2004 peak of 2.1 million deaths.
UNAIDS / WHO Estimates, 2025
31.6M
People accessing antiretroviral therapy (2024)
77% of all people living with HIV now receive ART — up from just 7.7 million in 2010. 9.2 million still lack lifesaving treatment.
UNAIDS 2025 Global AIDS Update
5.3M
People who don't know they have HIV (2024)
87% of all people living with HIV knew their status in 2024 — leaving 5.3 million unaware, undiagnosed, and unable to access treatment.
UNAIDS / WHO Estimates, 2025
44.1M
Total AIDS deaths since epidemic began
Since the epidemic was first identified in 1981, AIDS has killed 44.1 million people — one of the deadliest pandemics in recorded history.
WHO / UNAIDS cumulative data, 2025
📉 Progress vs The Target Gap
The world reduced new HIV infections by 61% since 1996 — but new infections in 2024 are still 3.5× the 2025 target
Global leaders committed to fewer than 370,000 new HIV infections by 2025. The actual 2024 figure — 1.3 million — is more than three times that target. While deaths have fallen by 70% since 2004, driven by ART scale-up, HIV prevention has stalled. The UNAIDS 2025 Global AIDS Update warns that without urgent action, 1.3 million new infections per year could become the new floor — not the ceiling.
Source: UNAIDS 2025 Global AIDS Update "AIDS, Crisis and the Power to Transform" · Published July 10, 2025 · UNAIDS/WHO estimates 2025
🚨
Section 2 — Breaking Development
The 2025 HIV Funding Crisis — A Threat to Decades of Progress
The UNAIDS 2025 Global AIDS Update sounded its most urgent alarm yet about a sudden collapse in international HIV funding that threatens to reverse 25 years of progress.
⚠️ 2025 Funding Emergency
If funding cuts are permanent: 6 million additional HIV infections and 4 million additional AIDS deaths projected by 2029
In early 2025, PEPFAR — the US President's Emergency Plan for AIDS Relief and the single largest contributor to the global HIV response — experienced unprecedented funding freezes and uncertainty. International assistance currently funds 80% of HIV prevention programmes in low- and middle-income countries, including Nigeria.
UNAIDS modelling shows that if PEPFAR does not return to its 2024 funding level, the 17% current funding gap could widen dramatically — potentially reversing progress to levels not seen since the early 2000s. Nigeria, which relies significantly on PEPFAR and the Global Fund, faces direct exposure to these funding disruptions for its antiretroviral supply chain and prevention programmes.
Source: UNAIDS 2025 Global AIDS Update · July 10, 2025 · UNAIDS modelling projections using Avenir Health Goals Model
80%
HIV prevention in LMICs funded by international aid
International assistance accounts for 80% of prevention programmes in low- and middle-income countries — making them highly vulnerable to funding cuts.
UNAIDS 2025 Global AIDS Update
26.9M
Lives saved by the HIV response since 1996
The global HIV response — led by PEPFAR, Global Fund, UNAIDS, and national governments — has saved an estimated 26.9 million lives since 1996.
UNAIDS 2025 Global AIDS Update
$21.9B
Annual funding needed for AIDS response by 2030
UNAIDS estimates USD 21.9 billion is needed annually by 2030 for the AIDS response in low- and middle-income countries — current funding falls well short.
UN / UNAIDS 2025
🌍
Section 3
HIV in Africa — Where the Epidemic Is Most Severe
Sub-Saharan Africa bears a disproportionate share of the global HIV burden. The WHO African Region alone accounts for more than two-thirds of all people living with HIV on earth.
21.1M
People living with HIV in Eastern & Southern Africa (2024)
More than half of all people living with HIV globally — 21.1 million — live in Eastern and Southern Africa alone. South Africa (9.2M) has the highest total.
UNAIDS Regional Data, 2024
63%
New HIV infections in sub-Saharan Africa that are women & girls
In sub-Saharan Africa, women and girls account for 63% of all new HIV infections — driven by gender inequality, gender-based violence, and age-disparate relationships.
UNAIDS Fact Sheet, 2025
4,000
Adolescent girls & young women infected with HIV every week globally (2024)
3,300 of these 4,000 weekly infections occur in sub-Saharan Africa. Young women aged 15–24 are up to 6× more likely to acquire HIV than young men in southern Africa.
UNAIDS / amfAR Global Statistics, 2024
84%
ART coverage in Eastern & Southern Africa (2024)
Eastern and Southern Africa leads the world in ART treatment coverage at 84% — with 7 countries (Botswana, Eswatini, Lesotho, Namibia, Rwanda, Zambia, Zimbabwe) hitting all three 95-95-95 targets.
UNAIDS 2025 Global AIDS Update
3.1%
HIV prevalence in the WHO African Region
Nearly 1 in every 30 adults in the WHO African Region lives with HIV — compared to the global average of 0.7%. Africa accounts for more than two-thirds of all people living with HIV worldwide.
WHO / UNAIDS, 2025
56.5→62.3
Life expectancy in sub-Saharan Africa (2010 vs 2024)
ART scale-up in sub-Saharan Africa increased average life expectancy from 56.5 years in 2010 to 62.3 years in 2024 — one of the most remarkable public health achievements of this century.
hiv.gov / UNAIDS ART data, 2024
🇳🇬
Section 4 — Nigeria Deep Dive
Nigeria: 4th Highest HIV Burden in the World
Nigeria has the 4th highest number of people living with HIV of any country on earth — behind South Africa, Kenya, and Mozambique — despite having one of the lower prevalence rates on the continent.
Nigeria HIV/AIDS Statistics
World's 4th Highest Burden
~2M
People living with HIV in Nigeria (2024)
WHO / Wikipedia HIV Prevalence Data, 2024
1.3%
National HIV prevalence (adults 15–49)
NAIIS / NACA — National Survey, 2018/2019
1.6M+
Nigerians on antiretroviral treatment
PEPFAR / NACA, 2024–2025
87%
People with HIV who know their status (2025)
NACA DG Dr. Ilori, December 2025
Nigeria is the 4th most affected country in the world by absolute HIV numbers — with an estimated 2 million to 2.45 million people living with HIV in 2024. Despite the country's HIV prevalence of 1.3% being relatively moderate by sub-Saharan African standards, Nigeria's massive population of over 229 million means even a low percentage translates into millions of people.
The NAIIS (Nigeria National HIV/AIDS Indicator and Impact Survey) — the most comprehensive HIV survey Nigeria has ever conducted — revised the national prevalence downward from 2.8% to 1.3–1.4%, based on household surveys across all 36 states and the FCT. While this revision was good news, it revealed persistent geographic and gender disparities. Eight states — Akwa Ibom, Rivers, Benue, Lagos, Anambra, Delta, Abia, and Enugu — account for over half of all people living with HIV in Nigeria.
Women face disproportionate risk: HIV prevalence among Nigerian women (1.9%) is more than double that of men (0.9%). Young women aged 20–24 are more than three times as likely to be living with HIV as young men in the same age group. In 2021, 14,000 young women aged 15–24 acquired HIV in Nigeria, compared to just 3,600 young men.
Remarkable treatment progress: NACA Director-General Dr. Temitope Ilori announced in December 2025 that Nigeria has achieved 87% status awareness, 98% treatment coverage among those who know their status, and 95% viral suppression among those on treatment — meeting two of the three 95-95-95 UNAIDS targets. Over 1.6 million Nigerians out of an estimated 2 million living with HIV now receive antiretroviral treatment through PEPFAR and the Global Fund.
The PEPFAR threat: Nigeria's HIV response depends heavily on PEPFAR funding. The 2025 funding uncertainty directly threatens the supply of antiretrovirals and prevention programmes for millions of Nigerians. The National Agency for the Control of AIDS (NACA) has called for urgent domestic resource mobilisation to reduce this dependence.
🗺️
Section 5
HIV by Region — 2024
HIV affects every region of the world, but with dramatically different burdens. Eastern and Southern Africa accounts for more people living with HIV than the rest of the world combined.
📋
Section 6 — Quick Reference
Key HIV/AIDS Statistics at a Glance
All headline statistics in one verifiable table — spanning historical data and the most current 2024/2025 estimates. Cite with attribution to primary sources.
HIV/AIDS — Master Data Table
Cite with attribution to enavecpharmacy.com
| Statistic | Figure | Year | Source |
|---|---|---|---|
| People living with HIV globally | 40.8 million | 2024 | UNAIDS / WHO Estimates, 2025 |
| People living with HIV globally (adults 15+) | 39.4 million | 2024 | UNAIDS / WHO Estimates, 2025 |
| Children (0–14) living with HIV globally | 1.4 million | 2024 | UNAIDS / WHO Estimates, 2025 |
| New HIV infections globally | 1.3 million | 2024 | UNAIDS 2025 Global AIDS Update |
| AIDS-related deaths globally | 630,000 | 2024 | UNAIDS / WHO Estimates, 2025 |
| Peak AIDS deaths (year of highest mortality) | 2.1 million | 2004 | UNAIDS historical data |
| Total cumulative AIDS deaths since 1981 | 44.1 million | 2024 | WHO / UNAIDS, 2025 |
| Total cumulative HIV infections since 1981 | 91.4 million | 2024 | UN / UNAIDS, 2025 |
| People on antiretroviral therapy globally | 31.6 million (77%) | 2024 | UNAIDS 2025 Global AIDS Update |
| People unaware of their HIV status | 5.3 million | 2024 | UNAIDS Fact Sheet, 2025 |
| Lives saved by HIV response since 1996 | 26.9 million | 2024 | UNAIDS 2025 Global AIDS Update |
| HIV prevalence — global (adults 15–49) | 0.7% | 2024 | UNAIDS / WHO, 2025 |
| HIV prevalence — WHO African Region | 3.1% | 2024 | WHO UNAIDS, 2025 |
| People living with HIV in Eastern & Southern Africa | 21.1 million | 2024 | UNAIDS Regional Data, 2025 |
| Women & girls — share of new infections in sub-Saharan Africa | 63% | 2024 | UNAIDS Fact Sheet, 2025 |
| Nigeria — people living with HIV (WHO estimate) | ~2 million | 2024 | WHO / Wikipedia HIV Prevalence, 2024 |
| Nigeria — HIV prevalence (adults 15–49) | 1.3% | 2018/2019 | NAIIS / NACA, 2019 |
| Nigeria — previous HIV prevalence estimate | 2.8% | Pre-2018 | Antenatal sentinel surveys |
| Nigeria — peak HIV prevalence | 5.8% | 2001 | NACA National HIV Framework 2021–2025 |
| Nigeria — Nigerians on ART | 1.6 million+ | 2024 | PEPFAR / NACA, 2024 |
| Nigeria — status awareness | 87% | 2025 | NACA DG Dr. Ilori, Dec 2025 |
| Nigeria — treatment coverage among those who know status | 98% | 2025 | NACA DG Dr. Ilori, Dec 2025 |
| South Africa — people living with HIV (world's highest) | 9.2 million | 2024 | Wikipedia / UNAIDS 2024 |
| Global new infections — reduction since 1996 peak | 61% decline | 2024 vs 1996 | UNAIDS 2025 |
📅
Section 7
Historical Timeline — From First Case to 2025 Crisis
From the first clinical reports in 1981 to the world's first long-acting HIV prevention injection in 2024 — the history of HIV/AIDS spans over four decades of tragedy, science, and progress.
June 1981
First clinical evidence of AIDS reported in the USA
Scientists at the US CDC report unusual cases of Pneumocystis pneumonia in five young gay men in Los Angeles — the first clinical evidence of what would become known as AIDS. The cause, HIV, would not be identified until 1983.
Source: CDC MMWR, June 5, 1981
1983
HIV virus identified by Françoise Barré-Sinoussi and Luc Montagnier
French scientists identify the Human Immunodeficiency Virus (HIV) as the cause of AIDS — a discovery that would earn them the Nobel Prize in Physiology or Medicine in 2008. The identification of the virus opens the door to treatment development.
Source: Science Journal, 1983 · Nobel Prize records, 2008
1987
AZT — first antiretroviral drug approved by FDA
The FDA approves AZT (zidovudine) as the first antiretroviral drug for AIDS treatment. While expensive and with significant side effects, it marks the beginning of HIV as a potentially treatable disease rather than an immediate death sentence.
Source: FDA approval records, 1987
1996
HIV peak: 3.4 million new infections in one year / Combination ART introduced
1996 marks the peak of new global HIV infections at 3.4 million in a single year. The same year, combination antiretroviral therapy (ART) — using multiple drugs — is introduced, dramatically reducing AIDS deaths in wealthy countries. The era of HIV as a manageable chronic condition begins.
Source: UNAIDS / International AIDS Conference, Vancouver, 1996
2003
PEPFAR launched — largest HIV funding commitment in history
US President George W. Bush announces the President's Emergency Plan for AIDS Relief (PEPFAR) — committing $15 billion over 5 years. PEPFAR would go on to save an estimated 25+ million lives in sub-Saharan Africa, making it the most impactful global health initiative ever undertaken.
Source: US State Department / PEPFAR records, 2003
2018–2019
Nigeria's NAIIS survey revises HIV prevalence from 2.8% to 1.3%
Nigeria conducts the most comprehensive HIV survey in its history — the Nigeria National HIV/AIDS Indicator and Impact Survey (NAIIS) — across all 36 states. The revised national prevalence of 1.3–1.4% (down from 2.8%) changes the global understanding of Nigeria's HIV epidemic and frees up more targeted resources.
Source: NACA / FMOH / PEPFAR / UNAIDS, 2019
2024
💉 Lenacapavir approved — the first 6-month injectable HIV prevention
The FDA approves lenacapavir (Sunlenca) for HIV prevention — a twice-yearly injection showing near-100% efficacy in preventing HIV in clinical trials. UNAIDS hails it as a potential HIV prevention revolution, but access and pricing remain critical challenges for sub-Saharan Africa.
Source: FDA / UNAIDS 2025 Global AIDS Update
Early 2025
🚨 PEPFAR funding crisis threatens to reverse 25 years of progress
Unprecedented funding freezes surrounding PEPFAR in early 2025 disrupt HIV treatment and prevention programmes across sub-Saharan Africa. UNAIDS warns this could result in 6 million additional HIV infections and 4 million additional deaths by 2029 if not reversed.
Source: UNAIDS 2025 Global AIDS Update · July 10, 2025
💊
Section 8
HIV Treatment Landscape — 2025 Status
HIV treatment has advanced dramatically — from a death sentence in the 1980s to a manageable chronic condition in 2025. But access remains deeply unequal between wealthy and developing nations.
Antiretroviral Therapy (ART)
Daily oral combination therapy that suppresses HIV to undetectable levels. People on effective ART live near-normal lifespans and cannot transmit the virus sexually (U=U: Undetectable = Untransmittable). 31.6 million people globally are now on ART.
Gold Standard
Cabotegravir (Long-Acting Injectable)
Cabotegravir is a long-acting injectable ART given every 2 months — eliminating the burden of daily pills. Approved in the US and UK. High efficacy data but access in Nigeria and Africa remains extremely limited due to cost.
Approved (US/UK)
Lenacapavir (HIV Prevention)
Twice-yearly injection for HIV prevention showing near-100% efficacy in trials. FDA approved in 2024. UNAIDS calls it a "prevention revolution" — but the list price (~$40,000/year in the USA) means Africa access depends entirely on generic production and price negotiations.
Approved 2024 (Prevention)
PrEP (Pre-Exposure Prophylaxis)
Daily oral pill for HIV-negative people at high risk — reduces HIV acquisition by 99% when taken consistently. Global PrEP use reached 3.9 million in 2024, up from 200,000 in 2017. Still far below the 21.2 million who could benefit from it.
Prevention (Oral)
PMTCT (Mother-to-Child Prevention)
ART given to HIV-positive pregnant women prevents mother-to-child HIV transmission. 84% of pregnant women living with HIV globally had access in 2024. Between 2000–2024, PMTCT programmes averted nearly 4.4 million new HIV infections in children.
Critical Programme
Functional Cure Research
Several patients have been "functionally cured" via bone marrow transplants (the Berlin, London, and City of Hope patients). CRISPR-based therapies targeting the HIV reservoir are in early clinical trials — a sterilising cure for the general population remains out of reach for now.
Research Phase
📌
Section 9 — Key Takeaways
What the Data Tells Us
-
1Extraordinary progress — but the job is not done. New infections fell 61% from the 1996 peak and AIDS deaths fell 70% from 2004. ART has saved 26.9 million lives. Yet 1.3 million new infections per year — more than 3× the 2025 target — and 630,000 annual deaths show the epidemic is far from over. (UNAIDS 2025)
-
2Nigeria's burden is larger than its prevalence rate suggests. A 1.3% prevalence sounds low — but in a country of 229 million people, it means approximately 2 million people living with HIV. Nigeria ranks 4th globally by absolute HIV numbers, and 8 states account for over half of all cases nationally. (NACA / WHO, 2024)
-
3Young women in sub-Saharan Africa face a catastrophic and gendered epidemic. 63% of new HIV infections in sub-Saharan Africa in 2024 were among women and girls. Young women aged 15–24 are up to 6× more likely to acquire HIV than young men. In Nigeria specifically, 14,000 young women vs 3,600 young men acquired HIV in 2021. (UNAIDS 2025 / healthsclinic.com)
-
4Nigeria has hit two of the three 95-95-95 targets — a major achievement. NACA announced in December 2025 that 87% of Nigerians living with HIV know their status, 98% of those who know are on treatment, and 95% on treatment are virally suppressed. The only unmet target is the first 95 (status awareness) — testing expansion is the critical next step. (NACA, December 2025)
-
5The 2025 funding crisis is the most serious threat to HIV progress in two decades. PEPFAR funding freezes in early 2025 directly threaten Nigeria's ART supply chain and prevention programmes. If not resolved, UNAIDS projects 6 million additional infections and 4 million additional deaths by 2029 globally. Nigeria must urgently scale domestic HIV funding. (UNAIDS 2025 Global AIDS Update)
❓
Section 10 — FAQ
Frequently Asked Questions
According to 2024 WHO data, approximately 2 million people in Nigeria live with HIV — including adults and children. Wikipedia's HIV Adult Prevalence database puts Nigeria at approximately 2.45 million by the start of 2024, making it the 4th highest in the world by absolute numbers (behind South Africa, Kenya, and Mozambique). Nigeria's national HIV prevalence among adults aged 15–49 is 1.3%, based on the comprehensive NAIIS household survey conducted across all 36 states. NACA Director-General Dr. Temitope Ilori announced in December 2025 that over 1.6 million Nigerians are now receiving antiretroviral treatment through PEPFAR and the Global Fund. (Sources: WHO 2024 / NACA / healthsclinic.com)
In 2024, approximately 630,000 people died from AIDS-related illnesses worldwide — equivalent to one person every single minute. This represents a remarkable 70% reduction from the peak of 2.1 million AIDS deaths in 2004. The reduction is almost entirely attributable to the scale-up of antiretroviral therapy. Children are disproportionately affected: 75,000 children died of AIDS-related causes in 2024, despite being only 3% of all people living with HIV. The UNAIDS 2025 global target was fewer than 250,000 AIDS deaths per year — the 630,000 actual figure means this target has been missed. (Source: UNAIDS / WHO Estimates, 2025)
HIV (Human Immunodeficiency Virus) is the virus itself. It attacks the immune system, specifically CD4+ T cells, gradually weakening the body's ability to fight infections and disease. A person can live with HIV for many years without developing AIDS — especially when on effective antiretroviral therapy. AIDS (Acquired Immunodeficiency Syndrome) is the most advanced stage of HIV infection, diagnosed when the CD4 count falls below 200 cells/mm³ or when certain AIDS-defining conditions (opportunistic infections such as tuberculosis, PCP pneumonia, or certain cancers) develop. With modern ART, people living with HIV who are diagnosed early and start treatment promptly can live their entire lives without ever developing AIDS. The key difference: HIV is the virus; AIDS is the late-stage disease caused by untreated HIV infection.
There is currently no widely available cure for HIV. However, several individuals have been "functionally cured" following bone marrow transplants — including the Berlin Patient, the London Patient, and the City of Hope Patient — who were treated for cancer and whose HIV was cleared in the process. These cases are not replicable at scale. What is available: Antiretroviral therapy (ART) suppresses HIV to undetectable levels and enables people with HIV to live near-normal lifespans without being able to transmit the virus sexually. For prevention, lenacapavir — a twice-yearly injection approved in 2024 — shows near-100% efficacy in preventing HIV acquisition. CRISPR gene-editing trials targeting the HIV reservoir are in early-stage human trials. A sterilising cure for the general population is not expected in the near term, but an effective cure pipeline exists. (FDA / UNAIDS 2025)
According to Nigeria's NAIIS survey and the National HIV and AIDS Strategic Framework 2021–2025, the states with the highest HIV burden are concentrated in South-South and South-East Nigeria. Eight states account for over half of all people living with HIV in Nigeria: Akwa Ibom, Rivers, Benue, Lagos, Anambra, Delta, Abia, and Enugu. Benue State in the North-Central zone is classified as a high prevalence state (above 2.0%). In the North-East, states like Taraba are medium-high prevalence. The South-South zone has the highest regional prevalence. Akwa Ibom consistently records the highest state-level HIV prevalence in Nigeria. (Source: NACA National HIV and AIDS Strategic Framework 2021–2025 / NAIIS 2018 data)
HIV is found in the bodily fluids of a person living with HIV — including blood, semen, vaginal fluids, rectal fluids, and breast milk. The main transmission routes in Nigeria and globally are: (1) Unprotected sexual contact — the most common route, particularly vaginal or anal intercourse. (2) Sharing needles/syringes — provides direct blood-to-blood contact among people who inject drugs. (3) Mother-to-child transmission (MTCT) — during pregnancy, childbirth, or breastfeeding. Without intervention, the transmission risk is 15–45%; with ART, this falls to below 2%. (4) Blood transfusions — rare in modern healthcare settings with proper screening. HIV is NOT transmitted through casual contact — hugging, shaking hands, sharing food, coughing, sneezing, mosquitoes, or toilet seats. (Source: WHO / NACA / healthsclinic.com)
🔍 Related Searches
📎
📎 How to Cite This Page
APA Format
Enavec Pharmacy. (2025, April). HIV/AIDS statistics [2025]: How many people have HIV globally and in Nigeria? Enavec Pharmacy. https://enavecpharmacy.com/hiv-aids-statistics
MLA Format
Enavec Pharmacy. "HIV/AIDS Statistics [2025]: How Many People Have HIV Globally and in Nigeria?" Enavec Pharmacy, April 2025, enavecpharmacy.com/hiv-aids-statistics.
Plain Text
Source: Enavec Pharmacy (April 2025). HIV/AIDS Statistics [2025]. Retrieved from enavecpharmacy.com/hiv-aids-statistics
📚 Primary Sources & Methodology
Every statistic on this page is sourced from UNAIDS, WHO, NACA, peer-reviewed journals, or official government health data. All sources are named, dated, and verifiable.
1
UNAIDS 2025 Global AIDS Update. "AIDS, Crisis and the Power to Transform." Published July 10, 2025. unaids.org/en/UNAIDS-global-AIDS-update-2025
2
UNAIDS / WHO Estimates, 2025. Global HIV & AIDS Statistics Fact Sheet 2025. unaids.org/en/resources/fact-sheet
3
WHO. HIV Data and Statistics. Global and Regional HIV Statistics Fact Sheet — July 2025. who.int/teams/global-hiv-hepatitis-and-stis-programmes/hiv/strategic-information/hiv-data-and-statistics
4
NACA Nigeria. Nigeria Prevalence Rate. National Agency for the Control of AIDS. naca.gov.ng/nigeria-prevalence-rate/
5
NACA Nigeria. National HIV and AIDS Strategic Framework 2021–2025. Federal Ministry of Health / NACA, Abuja. naca.gov.ng
6
healthsclinic.com. HIV in Nigeria: Statistics, Symptoms, Treatment & Care. Updated December 2025. healthsclinic.com/hiv-in-nigeria-statistics-symptoms-treatment-care
7
amfAR — The Foundation for AIDS Research. HIV/AIDS in the World. Global Statistics. amfar.org/about-hiv-aids/statistics-worldwide/ Updated 2024.
8
HIV.gov. HIV and AIDS Epidemic Global Statistics. US Department of Health and Human Services. hiv.gov/hiv-basics/overview/data-and-trends/global-statistics
9
Frontiers in Public Health. Prevalence and determinants of HIV among reproductive-age women in Africa from 2010 to 2019. Volume 12, 2024. doi: 10.3389/fpubh.2024.1376235
10
Wikipedia. HIV adult prevalence rate. Updated March 2026. Based on UNAIDS/WHO country-level data 2024. en.wikipedia.org/wiki/HIV_adult_prevalence_rate
11
UN.org. AIDS. United Nations Global Issues. un.org/en/global-issues/aids. UNAIDS data 2025.
12
Be in the KNOW. At a glance: HIV in Nigeria. beintheknow.org/understanding-hiv-epidemic/data/glance-hiv-nigeria. UNAIDS country data.
Found this helpful? Share it:
⚠️
Medical & Affiliate Disclaimer This article is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare provider before starting any supplement or medication. Some links in this post are affiliate links - if you purchase through them, Enavec Pharmacy may earn a small commission at no extra cost to you.
